-
1
-
-
0008953750
-
-
Washington, DC: US Department of Health and Human Services
-
Public Health Service Agency for Health Care Policy and Re-search (PHSAHCPR). Clinical practice guidelines: urinary incontinence in adults. Washington, DC: US Department of Health and Human Services, 1996
-
(1996)
Clinical Practice Guidelines: Urinary Incontinence in Adults
-
-
-
2
-
-
0032829435
-
Once-a-day controlled release versus immediate release oxybutynin chloride in the treatment of urinary urge incontinence
-
Anderson R, Mobley D, Blank B, et al. Once-a-day controlled release versus immediate release oxybutynin chloride in the treatment of urinary urge incontinence. J Urol 1999; 161: 1809-12
-
(1999)
J Urol
, vol.161
, pp. 1809-1812
-
-
Anderson, R.1
Mobley, D.2
Blank, B.3
-
3
-
-
0030997354
-
Tolterodine: A new bladder-selective antimuscarinic agent
-
Nilvebrant L, Andersson KE, Gillberg P, et al. Tolterodine: a new bladder-selective antimuscarinic agent. Eur J Pharmacol 1997; 327: 195-207
-
(1997)
Eur J Pharmacol
, vol.327
, pp. 195-207
-
-
Nilvebrant, L.1
Andersson, K.E.2
Gillberg, P.3
-
4
-
-
0344267753
-
Serum protein binding of tolterodine and its major metabolites in humans and several animal species
-
Pahlman I, Gozzi P. Serum protein binding of tolterodine and its major metabolites in humans and several animal species. Biopharm Drug Dispos 1999; 20: 91-9
-
(1999)
Biopharm Drug Dispos
, vol.20
, pp. 91-99
-
-
Pahlman, I.1
Gozzi, P.2
-
5
-
-
10044219977
-
-
Kalamazoo (MI): Pharmacia & Upjohn, Dec
-
Detrol LA package insert. Kalamazoo (MI): Pharmacia & Upjohn, Dec 2000
-
(2000)
Detrol LA Package Insert
-
-
-
6
-
-
0019495863
-
Osmotically activated dosage forms for rate-controlled drug delivery
-
Eckenhoff B, Theeuwes F, Urquhart J. Osmotically activated dosage forms for rate-controlled drug delivery. Pharm Technol 1981; 5: 35-44
-
(1981)
Pharm Technol
, vol.5
, pp. 35-44
-
-
Eckenhoff, B.1
Theeuwes, F.2
Urquhart, J.3
-
7
-
-
0028852647
-
Effects of food on the bioequivalence of different verapamil sustained-release formulations
-
Waldman SA, Morganroth J. Effects of food on the bioequivalence of different verapamil sustained-release formulations. J Clin Pharmacol 1995; 35: 163-9
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 163-169
-
-
Waldman, S.A.1
Morganroth, J.2
-
8
-
-
0030004756
-
Effect of food on the bioavailability of oxybutynin from a controlled release tablet
-
Lukkari E, Castern-Kortekangas P, Juhakoski A, et al. Effect of food on the bioavailability of oxybutynin from a controlled release tablet. Eur J Clin Pharmacol 1996; 50: 221-3
-
(1996)
Eur J Clin Pharmacol
, vol.50
, pp. 221-223
-
-
Lukkari, E.1
Castern-Kortekangas, P.2
Juhakoski, A.3
-
9
-
-
0024432379
-
Effect of food on nifedipine sustained-release preparation
-
Ueno K, Kawashima S, Uemoto K, et al. Effect of food on nifedipine sustained-release preparation. DICP 1989; 23: 662-5
-
(1989)
DICP
, vol.23
, pp. 662-665
-
-
Ueno, K.1
Kawashima, S.2
Uemoto, K.3
-
10
-
-
0035134318
-
Lack of effect of food on the pharmacokinetics of an extended-release oxybutynin formulation
-
Sathyan G, Hu W, Gupta SK. Lack of effect of food on the pharmacokinetics of an extended-release oxybutynin formulation. J Clin Pharmacol 2001; 41: 187-92
-
(2001)
J Clin Pharmacol
, vol.41
, pp. 187-192
-
-
Sathyan, G.1
Hu, W.2
Gupta, S.K.3
-
11
-
-
0035071434
-
Food does not influence the pharmacokinetics of a new extended-release formulation of tolterodine for once daily treatment of patients with overactive bladder
-
Olsson B, Szamosi J. Food does not influence the pharmacokinetics of a new extended-release formulation of tolterodine for once daily treatment of patients with overactive bladder. Clin Pharmacokinet 2001; 40: 135-43
-
(2001)
Clin Pharmacokinet
, vol.40
, pp. 135-143
-
-
Olsson, B.1
Szamosi, J.2
-
13
-
-
10044246422
-
The chemical level of organization
-
Tortora GJ, Anagnostakos NP, editors. San Francisco (CA): Harper & Row
-
Tortara GJ, Anagnostakos NP. The chemical level of organization. In: Tortora GJ, Anagnostakos NP, editors. Principles of anatomy and physiology. 4th ed. San Francisco (CA): Harper & Row, 1984:41
-
(1984)
Principles of Anatomy and Physiology. 4th Ed.
, pp. 41
-
-
Tortara, G.J.1
Anagnostakos, N.P.2
-
14
-
-
0028846970
-
The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil
-
Gupta SK, Yih BM, Atkinson L, et al. The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil. J Clin Pharmacol 1995; 35: 1083-93
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 1083-1093
-
-
Gupta, S.K.1
Yih, B.M.2
Atkinson, L.3
-
15
-
-
0033755350
-
Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects
-
Modi N, Wang B, Hu W, et al. Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects. Biopharm Drug Dispos 2000; 21: 23-31
-
(2000)
Biopharm Drug Dispos
, vol.21
, pp. 23-31
-
-
Modi, N.1
Wang, B.2
Hu, W.3
-
16
-
-
0022344421
-
Influence of food on the absorption of metoprolol administered as an OROS delivery system in man
-
Lecaillon JB, Massias P, Schoeller JP, et al. Influence of food on the absorption of metoprolol administered as an OROS delivery system in man. Br J Clin Pharmacol 1985; 19: 245-9S
-
(1985)
Br J Clin Pharmacol
, vol.19
-
-
Lecaillon, J.B.1
Massias, P.2
Schoeller, J.P.3
|